Christopher Timmermann
Consciousness and Psychedelic Neuroscience Researcher, Imperial College London
Imperial College London researcher specializing in the neuroscience of consciousness and psychedelic states, with landmark studies on DMT's effects on the dying brain and psilocybin's alteration of neural complexity.
Biography
Christopher Timmermann is a researcher at the Centre for Psychedelic Research at Imperial College London, where he works under the mentorship of Robin Carhart-Harris and David Nutt. His scientific focus sits at the intersection of consciousness science and psychedelic neuroscience — specifically, what psychedelics reveal about the neural basis of conscious experience.
Timmermann's most distinctive research involves DMT (dimethyltryptamine), where he has led some of the first controlled scientific studies of the compound's effects using neuroimaging. His work examining what happens to brain activity during near-death-like DMT states — including comparisons with cardiac arrest EEG data — has contributed to scientific understanding of how consciousness arises from neural activity and why psychedelic states so frequently produce mystical and near-death phenomenology. His 2023 research on intravenous DMT infusion, allowing researchers to extend and control the DMT state for neuroimaging purposes, was a significant methodological advance.
On psilocybin specifically, Timmermann has contributed to studies measuring neural complexity and 'neural entropy' under psychedelic states — the finding that psychedelics increase the diversity and complexity of brain activity in measurable ways. This entropy increase correlates with the subjective sense of expanded, less constrained consciousness that psychedelic users report. His work bridges the subjective phenomenology of psychedelic experience with its measurable neural signatures.
Organizations
Why They Matter to the LearnShrooms Community
Timmermann's consciousness-focused research connects the philosophical questions about what psychedelics do to the mind with precise neuroimaging measurements, advancing the scientific understanding of both psychedelic therapy and the nature of consciousness itself.
